Authors

• Michael Mæng (ORCID: https://orcid.org/0000-0002-4310-6433)
• Jonas Persson (ORCID: https://orcid.org/0000-0003-2162-0949)
• Lars Kjøller‐Hansen (ORCID: https://orcid.org/0000-0002-0819-5792)
• Ziad A. Ali (ORCID: https://orcid.org/0000-0002-2482-3197)
• Ori Ben‐Yehuda (ORCID: https://orcid.org/0000-0001-9199-1660)
• Tania Sharma
• Ole Fröbert (ORCID: https://orcid.org/0000-0002-5846-345X)
• Rune Wiseth (ORCID: https://orcid.org/0000-0002-5097-4554)
• Thomas Engstrøm (ORCID: https://orcid.org/0000-0001-5436-9194)
• Rebecca Tremain Rylance (ORCID: https://orcid.org/0000-0002-5921-3786)
• Alf Inge Larsen (ORCID: https://orcid.org/0000-0002-9141-0499)
• Stefan Karl James (ORCID: https://orcid.org/0000-0003-4413-9736)
• David Erlinge (ORCID: https://orcid.org/0000-0003-3042-5766)
• Akiko Maehara (ORCID: https://orcid.org/0000-0002-1910-8447)
• Mitsuaki Matsumura (ORCID: https://orcid.org/0000-0002-2082-0247)
• Gregg W. Stone
• Sasha Koul
• Gary S. Mintz

Institutions

• Uppsala University (SE)
• University of Copenhagen (DK)
• Karolinska University Hospital (SE)
• NewYork–Presbyterian Hospital (US)
• Lund University (SE)
• Cardiovascular Institute of the South (US)
• Örebro University (SE)
• Stavanger University Hospital (NO)
• New York Hospital Queens (US)
• Aarhus University Hospital (DK)
• Rigshospitalet (DK)
• Karolinska Institutet (SE)
• University of California San Diego (US)
• Zealand University Hospital (DK)
• St Olav's University Hospital (NO)
• Cardiovascular Research Foundation (US)
• Columbia University (US)
• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

International Journal of Cardiology Cardiovascular Risk and Prevention

Published

2025-05-24

DOI

https://doi.org/10.1016/j.ijcrp.2025.200440

Citations

2

Primary Topic

Protease and Inhibitor Mechanisms

Type

article

Field-Weighted Citation Impact

1.87

Funders

• Hjärt-Lungfonden
• Vetenskapsrådet